These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 33132050

  • 1. Long-Term Follow-Up of Mortality and Heart Failure Hospitalisation in Patients With Intracardiac Device-Related Tricuspid Regurgitation.
    Kanawati J, Ng ACC, Khan H, Yu C, Hyun K, Abed H, Kritharides L, Sy RW.
    Heart Lung Circ; 2021 May; 30(5):692-697. PubMed ID: 33132050
    [Abstract] [Full Text] [Related]

  • 2. Features of Lead-Induced Tricuspid Regurgitation in Patients With Heart Failure Events After Cardiac Implantation of Electronic Devices　- A Three-Dimensional Echocardiographic Study.
    Nakajima H, Seo Y, Ishizu T, Iida N, Sato K, Yamamoto M, Machino-Ohtsuka T, Nogami A, Ohte N, Ieda M.
    Circ J; 2020 Nov 25; 84(12):2302-2311. PubMed ID: 33071243
    [Abstract] [Full Text] [Related]

  • 3. Evolution and prognosis of tricuspid and mitral regurgitation following cardiac implantable electronic devices: a systematic review and meta-analysis.
    Yuyun MF, Joseph J, Erqou SA, Kinlay S, Echouffo-Tcheugui JB, Peralta AO, Hoffmeister PS, Boden WE, Yarmohammadi H, Martin DT, Singh JP.
    Europace; 2024 Jul 02; 26(7):. PubMed ID: 38812433
    [Abstract] [Full Text] [Related]

  • 4. Incidence, Risk Factors, and Prognosis of Tricuspid Regurgitation After Cardiac Implantable Electronic Device Implantation: A Systematic Review and Meta-analysis.
    Zhang XX, Wei M, Xiang R, Lu YM, Zhang L, Li YD, Zhang JH, Xing Q, Tu-Erhong ZK, Tang BP, Zhou XH.
    J Cardiothorac Vasc Anesth; 2022 Jun 02; 36(6):1741-1755. PubMed ID: 34389210
    [Abstract] [Full Text] [Related]

  • 5. Tricuspid regurgitation associated with implantable electrical device insertion: A systematic review and meta-analysis.
    Tatum R, Maynes EJ, Wood CT, Deb AK, Austin MA, O'Malley TJ, Choi JH, Massey HT, Morris RJ, Pavri BB, Tchantchaleishvili V.
    Pacing Clin Electrophysiol; 2021 Aug 02; 44(8):1297-1302. PubMed ID: 34081789
    [Abstract] [Full Text] [Related]

  • 6. Tricuspid regurgitation and implantable devices.
    Al-Bawardy R, Krishnaswamy A, Rajeswaran J, Bhargava M, Wazni O, Wilkoff B, Tuzcu EM, Martin D, Thomas J, Blackstone E, Kapadia S.
    Pacing Clin Electrophysiol; 2015 Feb 02; 38(2):259-66. PubMed ID: 25377489
    [Abstract] [Full Text] [Related]

  • 7. Significant lead-induced tricuspid regurgitation is associated with poor prognosis at long-term follow-up.
    Höke U, Auger D, Thijssen J, Wolterbeek R, van der Velde ET, Holman ER, Schalij MJ, Bax JJ, Delgado V, Marsan NA.
    Heart; 2014 Jun 02; 100(12):960-8. PubMed ID: 24449717
    [Abstract] [Full Text] [Related]

  • 8. Worsening tricuspid regurgitation associated with permanent pacemaker and implantable cardioverter-defibrillator implantation: A systematic review and meta-analysis of more than 66,000 subjects.
    Alnaimat S, Doyle M, Krishnan K, Biederman RWW.
    Heart Rhythm; 2023 Nov 02; 20(11):1491-1501. PubMed ID: 37506990
    [Abstract] [Full Text] [Related]

  • 9. Echocardiographic assessment of tricuspid regurgitation and pericardial effusion after cardiac device implantation.
    Wiechecka K, Wiechecki B, Kapłon-Cieślicka A, Tymińska A, Budnik M, Hołowaty D, Jakubowski K, Michalak M, Świętoń E, Stolarz P, Steckiewicz R, Grabowski M, Scisło P, Kochanowski J, Filipiak KJ, Opolski G.
    Cardiol J; 2020 Nov 02; 27(6):797-806. PubMed ID: 31225634
    [Abstract] [Full Text] [Related]

  • 10. Effects of pacemaker and implantable cardioverter defibrillator electrodes on tricuspid regurgitation and right sided heart functions.
    Arabi P, Özer N, Ateş AH, Yorgun H, Oto A, Aytemir K.
    Cardiol J; 2015 Nov 02; 22(6):637-44. PubMed ID: 26412607
    [Abstract] [Full Text] [Related]

  • 11. Incidence and Prognostic Implications of Cardiac-Implantable Device-Associated Tricuspid Regurgitation: A Meta-Analysis and Meta-Regression Analysis.
    Safiriyu I, Mehta A, Adefuye M, Nagraj S, Kharawala A, Hajra A, Shamaki GR, Kokkinidis DG, Bob-Manuel T.
    Am J Cardiol; 2023 Dec 15; 209():203-211. PubMed ID: 37863117
    [Abstract] [Full Text] [Related]

  • 12. Outcomes of TTVI in Patients With Pacemaker or Defibrillator Leads: Data From the TriValve Registry.
    Taramasso M, Gavazzoni M, Pozzoli A, Alessandrini H, Latib A, Attinger-Toller A, Biasco L, Braun D, Brochet E, Connelly KA, de Bruijn S, Denti P, Deuschl F, Estevez-Louriero R, Fam N, Frerker C, Ho E, Juliard JM, Kaple R, Kodali S, Kreidel F, Kuck KH, Lauten A, Lurz J, Monivas V, Mehr M, Nazif T, Nickening G, Pedrazzini G, Praz F, Puri R, Rodés-Cabau J, Schäfer U, Schofer J, Sievert H, Tang GHL, Khattab AA, Thiele H, Unterhuber M, Vahanian A, Von Bardeleben RS, Webb JG, Weber M, Windecker S, Winkel M, Zuber M, Hausleiter J, Lurz P, Maisano F, Leon MB, Hahn RT.
    JACC Cardiovasc Interv; 2020 Mar 09; 13(5):554-564. PubMed ID: 31954676
    [Abstract] [Full Text] [Related]

  • 13. Tricuspid Regurgitation Following Implantation of Endocardial Leads: Incidence and Predictors.
    Lee RC, Friedman SE, Kono AT, Greenberg ML, Palac RT.
    Pacing Clin Electrophysiol; 2015 Nov 09; 38(11):1267-74. PubMed ID: 26234305
    [Abstract] [Full Text] [Related]

  • 14. Comparison of Outcomes in Patients With Heart Failure With Versus Without Lead-Induced Tricuspid Regurgitation After Cardiac Implantable Electronic Devices Implantations.
    Seo Y, Nakajima H, Ishizu T, Iida N, Sato K, Yamamoto M, Machino-Ohtsuka T, Nogami A, Ohte N, Ieda M.
    Am J Cardiol; 2020 Sep 01; 130():85-93. PubMed ID: 32622503
    [Abstract] [Full Text] [Related]

  • 15. Lead-related tricuspid regurgitation and ventricle dysfunction: Current management and future perspectives.
    Chodór-Rozwadowska KE, Sawicka M, Morawski S, Lenarczyk R, Kalarus Z, Kukulski T.
    Adv Clin Exp Med; 2023 Sep 01; 32(9):1049-1061. PubMed ID: 36881368
    [Abstract] [Full Text] [Related]

  • 16. Cardiac Implantable Electronic Device Lead-Induced Tricuspid Regurgitation.
    Addetia K, Harb SC, Hahn RT, Kapadia S, Lang RM.
    JACC Cardiovasc Imaging; 2019 Apr 01; 12(4):622-636. PubMed ID: 30947905
    [Abstract] [Full Text] [Related]

  • 17. Surgical treatment of tricuspid valve regurgitation in patients with cardiac implantable electronic devices: long-term results.
    Carino D, Sala A, Zancanaro E, Ruggeri S, Lapenna E, Del Forno B, Verzini A, Schiavi D, Castiglioni A, Alfieri O, Maisano F, De Bonis M.
    Eur J Cardiothorac Surg; 2022 Aug 03; 62(3):. PubMed ID: 35426906
    [Abstract] [Full Text] [Related]

  • 18. Severe symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverter-defibrillator leads.
    Lin G, Nishimura RA, Connolly HM, Dearani JA, Sundt TM, Hayes DL.
    J Am Coll Cardiol; 2005 May 17; 45(10):1672-5. PubMed ID: 15893186
    [Abstract] [Full Text] [Related]

  • 19. Effect of tricuspid regurgitation and right ventricular dysfunction on long-term mortality in patients undergoing cardiac devices implantation: >10-year follow-up study.
    Papageorgiou N, Falconer D, Wyeth N, Lloyd G, Pellerin D, Speechly-Dick E, Segal OR, Lowe M, Rowland E, Lambiase PD, Chow AW, Bhattacharyya S.
    Int J Cardiol; 2020 Nov 15; 319():52-56. PubMed ID: 32470533
    [Abstract] [Full Text] [Related]

  • 20. Echocardiography-guided Cardiac Implantable Electronic Device Implantation to Reduce Device Related Tricuspid Regurgitation: A Prospective Controlled Study.
    Marincheva G, Levi T, Perelshtein Brezinov O, Valdman A, Rahkovich M, Kogan Y, Laish-Farkash A.
    Isr Med Assoc J; 2022 Jan 15; 24(1):25-32. PubMed ID: 35077042
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.